New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:03 EDTKND, GTIVKindred says disappointed, but not deterred, by Gentiva 'poison pill'
Kindred Healthcare (KND) announded it sent a letter to the Gentiva Health (GTIV) Board of Directors in response to the poison pill, also known as a “shareholder rights plan,” implemented by the Gentiva Board and disclosed by Gentiva on Friday, May 23. In the letter, Kindred stated in part: "Since the May 15, 2014 public announcement of our offer to acquire Gentiva for total consideration of $14.00 per share, we have heard from both companies’ shareholders – and sell-side research analysts have reported – that they support a combination and that the price is a very compelling and significant premium to Gentiva’s historic trading price and projected earnings estimates. We are certain you have heard the same from your shareholders. We are disappointed, however, that instead of listening to your shareholders – the true owners of Gentiva – and immediately entering into good faith negotiations with Kindred, your Board has instead implemented a poison pill that limits shareholders’ opportunity to maximize the value of their investment. We question the motive and timing of such implementation, which limits not just Kindred, but all Gentiva shareholders from increasing their investment in the company...Despite Gentiva’s actions, we will not be deterred. We are determined to pursue the proposed combination of Kindred and Gentiva and are committed over the long-term to achieving our objective. We are ready, willing and able to quickly proceed toward consummating a negotiated transaction."
News For KND;GTIV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
20:07 EDTKNDKindred Healthcare 5M share Secondary priced at $19.75
Subscribe for More Information
November 17, 2014
07:48 EDTKNDKindred Healthcare files to sell 5M shares of stock and tangible equity units
Kindred Healthcare announced that it has launched concurrent underwritten public offerings of 5,000,000 shares of Kindred's common stock and 150,000 tangible equity units. Each tangible equity unit has a stated amount of $1,000 and is comprised of a prepaid stock purchase contract and a share of mandatory redeemable preferred stock, each issued by the Company. Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are acting as the joint book-running managers for the concurrent offerings.
November 12, 2014
08:01 EDTKNDKindred Healthcare to acquire Centerre Healthcare for $195M in cash
Kindred Healthcare announced that it has signed a definitive merger agreement to acquire Centerre Healthcare Corporation, a national company dedicated to operating Inpatient Rehabilitation Hospitals, for a purchase price of approximately $195M in cash. Centerre currently operates 11 Inpatient Rehabilitation Hospitals with 612 beds in partnership with some of the nation’s leading acute care hospital systems through joint ventures. Centerre has two additional hospitals with a total of 90 beds under construction and scheduled to open in 2015, and a pipeline of additional potential hospitals in various stages of development.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use